http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2462711-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3dabba1ab5421f7ad162a53fce8e4f6 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 |
filingDate | 2011-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2012-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9da7a175092249868a0b0a89cec5672 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de36ca42c34407a4eaa227a532c41afa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54949d3c09a1a316e4d47130a718e25d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58968de5271c996f57f7f11eb3d8492f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_941f603656f5395448fe647a113fff71 |
publicationDate | 2012-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2462711-C1 |
titleOfInvention | Method for laboratory verification of infections in patients with acute manifested myeloid leukemia |
abstract | FIELD: medicine. n SUBSTANCE: invention aims at stating the presence of an infection in patients with acute manifested myeloid leukemia. It involves body temperature measurement, leukocyte, blast cell and C-reactive protein (CRP) count. If the CRP level is less than 12 mg/l, the infection is excepted. The CRP level more than 40 mg/l enables stating the presence of the infection regardless of leukocyte and blast cell count. n EFFECT: method enables early diagnosing of infectious complications in the acute disease state. n 2 tbl, 2 ex |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2535057-C1 |
priorityDate | 2011-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 164.